Segment & Geographic Data
Quant-Grade Normalized Data
API & CSV Delivery
Misonix Inc's Business Segments
Misonix Inc's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Reportable Segments
-
Largest Segment
-
Total Revenue
-
Regions Reported
1
API endpoints for this dataset
https://api.csimarket.com/api/v1/companies/MSON/segments
https://api.csimarket.com/api/v1/companies/MSON/geographic
https://api.csimarket.com/api/v1/companies/MSON/exposure
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Connect Your AI Assistant
Annual Results
Revenue Share by Region -
- Geographic Distribution Foreign18.1%
Revenue by Geographic Region -
| Region | Revenue (Millions) | % of Total |
|---|---|---|
| Geographic Distribution Foreign | $ 13 | 18.1% |
Description of Misonix Inc
Misonix Inc. is a medical device company that specializes in developing and marketing advanced therapeutic ultrasonic surgical systems. The company was founded in 1959 and is headquartered in Farmingdale, New York.
Misonix is focused on transforming the way surgeries are performed by delivering innovative, cutting-edge solutions that improve patient outcomes. They primarily operate in two major segments: Surgical and wound management.
The Surgical segment offers several products including the SonicOne O.R. System, which is a comprehensive system for surgical wound debridement. This system utilizes a high-frequency ultrasonic technology to remove necrotic tissue, bacteria, and other unwanted substances from wounds, promoting faster healing and preventing infections.
Another key product in the surgical segment is the BoneScalpel, a precision cutting system that uses ultrasonic technology to provide surgeons with a safe and efficient solution for bone dissection and removal, reducing the risk of damage to surrounding soft tissues.
In the wound management segment, Misonix provides the TheraSkin product, which is a bioengineered human skin substitute that aids in the healing of chronic wounds. TheraSkin is used in the treatment of diabetic foot ulcers, venous leg ulcers, pressure ulcers, and surgical wounds, among others.
Misonix also offers other advanced products and solutions, including the Nexus wound care system, which combines ultrasonic debridement with negative pressure wound therapy, and the AutoSonic system, an ultrasonic surgical aspirator for use in various neurosurgical procedures.
The company sells its products both in the United States and internationally. They have a direct sales force in the U.S. and operate through a network of distributors and strategic partners worldwide. Misonix focuses on building strong relationships with healthcare professionals, ensuring comprehensive training and support to ensure optimal use of their products.
Misonix is committed to ongoing research and development to drive innovation in the medical field. They collaborate with leading surgeons and medical institutions to gather feedback and insights for product improvements.
As a company, Misonix firmly believes in ethical business practices. They strive to maintain the highest standards of integrity, quality, and transparency in all aspects of their operations.
In conclusion, Misonix Inc. is an established medical device company that specializes in therapeutic ultrasonic surgical systems. With their innovative products and solutions, they aim to revolutionize surgical procedures and wound management, ultimately improving patient outcomes and quality of life.
Misonix is focused on transforming the way surgeries are performed by delivering innovative, cutting-edge solutions that improve patient outcomes. They primarily operate in two major segments: Surgical and wound management.
The Surgical segment offers several products including the SonicOne O.R. System, which is a comprehensive system for surgical wound debridement. This system utilizes a high-frequency ultrasonic technology to remove necrotic tissue, bacteria, and other unwanted substances from wounds, promoting faster healing and preventing infections.
Another key product in the surgical segment is the BoneScalpel, a precision cutting system that uses ultrasonic technology to provide surgeons with a safe and efficient solution for bone dissection and removal, reducing the risk of damage to surrounding soft tissues.
In the wound management segment, Misonix provides the TheraSkin product, which is a bioengineered human skin substitute that aids in the healing of chronic wounds. TheraSkin is used in the treatment of diabetic foot ulcers, venous leg ulcers, pressure ulcers, and surgical wounds, among others.
Misonix also offers other advanced products and solutions, including the Nexus wound care system, which combines ultrasonic debridement with negative pressure wound therapy, and the AutoSonic system, an ultrasonic surgical aspirator for use in various neurosurgical procedures.
The company sells its products both in the United States and internationally. They have a direct sales force in the U.S. and operate through a network of distributors and strategic partners worldwide. Misonix focuses on building strong relationships with healthcare professionals, ensuring comprehensive training and support to ensure optimal use of their products.
Misonix is committed to ongoing research and development to drive innovation in the medical field. They collaborate with leading surgeons and medical institutions to gather feedback and insights for product improvements.
As a company, Misonix firmly believes in ethical business practices. They strive to maintain the highest standards of integrity, quality, and transparency in all aspects of their operations.
In conclusion, Misonix Inc. is an established medical device company that specializes in therapeutic ultrasonic surgical systems. With their innovative products and solutions, they aim to revolutionize surgical procedures and wound management, ultimately improving patient outcomes and quality of life.
Misonix Inc. is a medical device company primarily focused on developing innovative, ultrasonic-based technologies for surgical and wound care applications. The product portfolio can be categorized into several segments, each targeting specific medical needs and offering a range of products and services.
Segments
1. Surgical Ultrasonics
- This segment primarily deals with ultrasound technology used in surgical environments. Misonixs ultrasonic devices are designed to aid surgeons in performing complex procedures with precision and control.
2. Wound Care
- Misonix provides products focused on the treatment of chronic and acute wounds. These include advanced wound cleansing and debridement technologies, aimed at enhancing healing while minimizing pain and discomfort for patients.
3. Bone Surgery
- The bone surgery segment focuses on tools for orthopedic surgery, particularly in procedures that require bone cutting, shaping, or removal. The technology facilitates less invasive procedures with reduced damage to surrounding tissues.
4. Interventional Oncology
- Misonix develops solutions for interventional procedures aimed at treating tumors and other pathological conditions. This includes ultrasound-assisted technologies that help guide interventions more accurately and effectively.
Products
1. Ultrasonic Surgical Devices
- Sonastar: A surgical tool designed for soft tissue procedures, utilizing high-frequency ultrasonic vibration to enhance cutting and coagulation.
- BoneScalpel: A device specifically engineered for bone surgery, providing precise cutting with minimal thermal injury to surrounding tissue.
2. Wound Management Products
- Aspire: A system used for negative pressure wound therapy (NPWT) that facilitates the removal of exudate and promotes a conducive environment for healing.
- Misonix Wound Debridement Devices: These products utilize ultrasonic energy to painlessly remove necrotic tissue and debris from wounds, promoting better healing outcomes.
3. Interventional Devices
- SonicOne: Designed for use in the interventional oncology space, SonicOne leverages ultrasound energy for more effective tumor ablation, offering a minimally invasive alternative to traditional methods.
Services
1. Training and Support
- Misonix provides extensive training for healthcare professionals on the proper usage of their devices. This includes hands-on workshops, online resources, and ongoing support to ensure optimal patient outcomes.
2. Technical Support
- The company offers technical support for their devices, ensuring that medical facilities can maintain their equipment and resolve any issues that arise during usage.
3. Clinical Education
- Misonix engages in continuous medical education initiatives aimed at keeping healthcare providers informed about the latest advancements in ultrasonic technology and best practices in their usage.
4. Partnerships and Collaborations
- Misonix actively seeks collaboration opportunities with hospitals, clinics, and research institutions to explore new applications of their technology, contributing to improved surgical techniques and patient care protocols.
Conclusion
Misonixs commitment to advancing medical technology through ultrasonic applications positions it as a leader in its field. By focusing on surgical, wound care, bone surgery, and interventional oncology, the company provides integrated solutions that enhance surgical precision, improve patient outcomes, and promote efficient healing in various medical settings. Their comprehensive approach, encompassing products, training, and support services, underscores their dedication to healthcare professionals and patients alike.
Segments
1. Surgical Ultrasonics
- This segment primarily deals with ultrasound technology used in surgical environments. Misonixs ultrasonic devices are designed to aid surgeons in performing complex procedures with precision and control.
2. Wound Care
- Misonix provides products focused on the treatment of chronic and acute wounds. These include advanced wound cleansing and debridement technologies, aimed at enhancing healing while minimizing pain and discomfort for patients.
3. Bone Surgery
- The bone surgery segment focuses on tools for orthopedic surgery, particularly in procedures that require bone cutting, shaping, or removal. The technology facilitates less invasive procedures with reduced damage to surrounding tissues.
4. Interventional Oncology
- Misonix develops solutions for interventional procedures aimed at treating tumors and other pathological conditions. This includes ultrasound-assisted technologies that help guide interventions more accurately and effectively.
Products
1. Ultrasonic Surgical Devices
- Sonastar: A surgical tool designed for soft tissue procedures, utilizing high-frequency ultrasonic vibration to enhance cutting and coagulation.
- BoneScalpel: A device specifically engineered for bone surgery, providing precise cutting with minimal thermal injury to surrounding tissue.
2. Wound Management Products
- Aspire: A system used for negative pressure wound therapy (NPWT) that facilitates the removal of exudate and promotes a conducive environment for healing.
- Misonix Wound Debridement Devices: These products utilize ultrasonic energy to painlessly remove necrotic tissue and debris from wounds, promoting better healing outcomes.
3. Interventional Devices
- SonicOne: Designed for use in the interventional oncology space, SonicOne leverages ultrasound energy for more effective tumor ablation, offering a minimally invasive alternative to traditional methods.
Services
1. Training and Support
- Misonix provides extensive training for healthcare professionals on the proper usage of their devices. This includes hands-on workshops, online resources, and ongoing support to ensure optimal patient outcomes.
2. Technical Support
- The company offers technical support for their devices, ensuring that medical facilities can maintain their equipment and resolve any issues that arise during usage.
3. Clinical Education
- Misonix engages in continuous medical education initiatives aimed at keeping healthcare providers informed about the latest advancements in ultrasonic technology and best practices in their usage.
4. Partnerships and Collaborations
- Misonix actively seeks collaboration opportunities with hospitals, clinics, and research institutions to explore new applications of their technology, contributing to improved surgical techniques and patient care protocols.
Conclusion
Misonixs commitment to advancing medical technology through ultrasonic applications positions it as a leader in its field. By focusing on surgical, wound care, bone surgery, and interventional oncology, the company provides integrated solutions that enhance surgical precision, improve patient outcomes, and promote efficient healing in various medical settings. Their comprehensive approach, encompassing products, training, and support services, underscores their dedication to healthcare professionals and patients alike.